Patent · US Active

Antibody molecules to CD138 and uses thereof

US11945868B2 · kind B2 · utility

1Cited by

16References

37Claims

0Family size

Assignee

Visterra, Inc. · US

Inventors

Bharat Chaganty · Concord, US
Boopathy Ramakrishnan · Braintree, US
Hedy Adari-Hall · Sudbury, US
Karthik Viswanathan · Waltham, US
James R. Myette · Waltham, US
Zachary Shriver · Winchester, US

Key dates

Filing date	Oct 2, 2018
Grant date	Apr 2, 2024
Priority date	—
Expiry date	Oct 16, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Antibody molecules that specifically bind to CD138 are disclosed. The antibody molecules can be used to treat, prevent, and/or diagnose disorders, such as multiple myeloma.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.